Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
insulin glargine (toujeo) (1 trial)
pioglitazone (actos) (1 trial)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Neoplasm Metastasis (Phase 4)
Trials (1 total)
Trial APIs (2 total)